(Q37983706)

26 August 2017

The risks of PPI therapy (English)

1 reference

26 August 2017

1

Paul Moayyedi

1 reference

26 August 2017

Grigorios I Leontiadis

series ordinal

2

1 reference

PubMed ID

22330810

26 August 2017

language of work or name

English

0 references

publication date

14 February 2012

1 reference

Nature Reviews Gastroenterology & Hepatology

26 August 2017

1 reference

26 August 2017

9

1 reference

26 August 2017

3

1 reference

26 August 2017

132-139

1 reference

https://scigraph.springernature.com/pub.10.1038/nrgastro.2011.272

26 August 2017

0 references

cites work

Review article: gastro-oesophageal reflux disease--the extent of the problem.

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

The effect of dexlansoprazole MR on nocturnal heartburn and GERD-related sleep disturbances in patients with symptomatic GERD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

The gain in quality-adjusted life months by switching to esomeprazole in those with continued reflux symptoms in primary care: EncomPASS--a cluster-randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

A pharmacokinetic study comparing single and repeated oral doses of 20 mg and 40 mg omeprazole and its two optical isomers, S-omeprazole (esomeprazole) and R-omeprazole, in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Acid inhibition and infections outside the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Proton-pump inhibitor use and the risk for community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Acid-suppressive medication use and the risk for hospital-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Acid-suppressive drugs and community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

The problem of "protopathic bias" in case-control studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Association between proton pump inhibitors and respiratory infections: a systematic review and meta-analysis of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Occurrence of community-acquired respiratory tract infection in patients receiving esomeprazole: retrospective analysis of adverse events in 31 clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Systematic review of the risk of enteric infection in patients taking acid suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Clostridium difficile--more difficult than ever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

A hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

A case-control study of community-associated Clostridium difficile infection: no role for proton pump inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Germination of spores of Clostridium difficile strains, including isolates from a hospital outbreak of Clostridium difficile-associated disease (CDAD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Proton pump inhibitors and risk for recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Proton pump inhibitor use and enteric infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Prevention of endemic healthcare-associated Clostridium difficile infection: reviewing the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Meta-analysis: risk of fractures with acid-suppressing medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Use of acid-suppressive drugs and risk of fracture: a meta-analysis of observational studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Long-term proton pump inhibitor therapy and risk of hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Acid-suppressive medications and risk of bone loss and fracture in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Use of proton pump inhibitors and risk of osteoporosis-related fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Increase in vertebral fracture risk in postmenopausal women using omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Regulation of vitamin D and calcium metabolism after gastrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Inhibiting gastric acid production does not affect intestinal calcium absorption in young, healthy individuals: a randomized, crossover, controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Do proton pump inhibitors decrease calcium absorption?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Hip fracture and proton pump inhibitor therapy: position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

A population-based study of the drug interaction between proton pump inhibitors and clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Cardiovascular and gastrointestinal outcomes in clopidogrel users on proton pump inhibitors: results of a large Dutch cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

PPIs and clopidogrel: the band plays on............

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Proton pump inhibitor and clopidogrel interaction: fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

The interaction between proton pump inhibitors and clopidogrel and upper gastrointestinal bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Clopidogrel with or without omeprazole in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Esomeprazole with clopidogrel reduces peptic ulcer recurrence, compared with clopidogrel alone, in patients with atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Impact of proton pump inhibitors on efficacy of clopidogrel: Review of evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

The potential interaction between clopidogrel and proton pump inhibitors: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Drug interaction between clopidogrel and proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Proton pump inhibitors and clopidogrel - hazardous drug interaction or hazardous interpretation of data?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Editorial: just how "difficult" is it to withdraw PPI treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Hip fracture and proton pump inhibitor therapy: balancing the evidence for benefit and harm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Overutilization of proton pump inhibitors: a review of cost-effectiveness and risk [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Proton-Pump Inhibitor Use Is Not Associated With Osteoporosis or Accelerated Bone Mineral Density Loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Proton Pump Inhibitor Use and Risk of Hip Fractures in Patients without Major Risk Factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Proton pump inhibitor treatment for acute peptic ulcer bleeding

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Treatment of GERD and proton pump inhibitor use in the elderly: practical approaches and frequently asked questions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Drug-induced hypochlorhydria causes high duodenal bacterial counts in the elderly

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Effect of L-lactic acid on calcium absorption in rats fed omeprazole

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Risk of fractures in patients with pernicious anemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Drug regulatory agencies' role in the interaction between clopidogrel and proton pump inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

CON: Evidence-Based Medicine-The Emperor's New Clothes?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.272

Meta-analysis: the effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrel.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22330810

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Proton pump inhibitor treatment for acute peptic ulcer bleeding

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22330810

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRGASTRO.2011.272

1 reference

PubMed ID

22330810

Dimensions Publication ID

26 August 2017

0 references

1 reference

PubMed ID

22330810